Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1527100
Reference Type
Journal Article
Title
Monitoring carbon dioxide in mechanically ventilated patients during hyperbaric treatment
Author(s)
Bjerregard, A; Jansen, E
Year
2012
Is Peer Reviewed?
Yes
Journal
Diving and Hyperbaric Medicine
ISSN:
1833-3516
Volume
42
Issue
3
Page Numbers
134-136
PMID
22987459
Web of Science Id
WOS:000308502400005
Abstract
(Bjerregard A, Jansen E. Monitoring carbon dioxide in mechanically ventilated patients during hyperbaric treatment. Diving and Hyperbaric Medicine. 2012;42(3):134-136.) Background: Measurement of the arterial carbon dioxide (PaCO2) is an established part of the monitoring of mechanically ventilated patients. Other ways to get information about carbon dioxide in the patient are measurement of end-tidal carbon dioxide (PETCO2) and transcutaneous carbon dioxide (PTCCO2). Carbon dioxide in the blood and cerebral tissue has great influence on vasoactivity and thereby blood volume of the brain. We have found no studies on the correlation between PETCO2 or PTCCO2, and PaCO2 during hyperbaric oxygen therapy (HBOT). Method: We studied 10 intubated and ventilatory stable patients during HBOT. End-tidal and transcutaneous measurements provided continuous data. Arterial blood samples were collected after reaching the operational pressure of 284 kPa (2.8 ATA) and analysed outside the chamber. A total of 17 paired samples of PETCO2, PTCCO2 and PaCO2 were obtained. Results: There was a good correlation between PETCO2 and PaCO2 using linear regression (r(2) = 0.83). Bland-Altman analysis showed that PETCO2 on average was 2.22 kPa higher than PaCO2 with limits of agreement (LoA) at +/- 2.4 kPa. PTCCO2, on average, was 2.16 kPa lower than PaCO2 and the correlation using linear regression was poor (r(2) = 0.24). Bland-Altman analysis revealed LoA at +/- 3.2 kPa. Conclusion: During hyperbaric conditions we found that PETCO2 as opposed to PTCCO2 offered the greater precision, but there was great variability among patients. Care must be taken when using PETCO2 or PTCCO2 as an estimate of PaCO2.
Keywords
Patient monitoring; carbon dioxide; hypercapnia; hyperbaric oxygen therapy; ventilators
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity